Revenue from Contract with Customer, Excluding Assessed Tax in USD of iBio, Inc. from Q3 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
iBio, Inc. quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax history and change rate from Q3 2022 to Q3 2025.
  • iBio, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Sep 2025 was $100,000.
  • iBio, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending 30 Sep 2025 was $500,000.
  • iBio, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2025 was $400,000, a 78% increase from 2024.
  • iBio, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $225,000.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)

iBio, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $500,000 $100,000 +$100,000 01 Jul 2025 30 Sep 2025 10-Q/A 17 Nov 2025 2026 Q1
Q2 2025 $400,000 $200,000 01 Apr 2025 30 Jun 2025 10-K 05 Sep 2025 2025 FY
Q1 2025 $0 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q3
Q4 2024 $200,000 01 Oct 2024 31 Dec 2024 10-Q 10 Feb 2025 2025 Q2
Q3 2024 $0 -$50,000 -100% 01 Jul 2024 30 Sep 2024 10-Q/A 17 Nov 2025 2026 Q1
Q3 2023 $50,000 +$50,000 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2025 Q1
Q3 2022 $0 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1

iBio, Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $400,000 +$175,000 +78% 01 Jul 2024 30 Jun 2025 10-K 05 Sep 2025 2025 FY
2024 $225,000 +$225,000 01 Jul 2023 30 Jun 2024 10-K 05 Sep 2025 2025 FY
2023 $0 01 Jul 2022 30 Jun 2023 10-K/A 24 Sep 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.